![](/img/cover-not-exists.png)
[American Thoracic Society American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX - ()] B68. ONCOGENIC MUTATIONS, METASTASIS, AND NOVEL THERAPEUTICS - Clinical Significance of Sequential Treatment with Afatinib in the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Treatment of Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
Kobayashi, N., Aiko, H., Kamimaki, C., Mikami, N., Kubo, S., Tei, Y., Hirama, N., Katakura, S., Teranishi, S., Manabe, S., Yamamoto, M., Kudo, M., Kaneko, T.DOI:
10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3935
File:
PDF, 19 KB